TERT Promoter Mutations Frequency Across Race, Sex, and Cancer Type.
Amin H NassarMarc MachaalaniRashad NawfalAmin H NassarWanling XieToni K ChoueiriMark M PomerantzPublished in: The oncologist (2023)
The prevalence of TERT gene promoter mutations varies among patients with cancer based on race and sex. These findings inform our understanding of cancer biology and can assist in the design of future clinical trials that leverage drugs targeting TERT promoter dependencies.